Achillion to Present at the Credit Suisse 24th Annual Healthcare Conference
November 02 2015 - 6:05AM
Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN)
announced today that Milind Deshpande, Ph.D., President and Chief
Executive Officer of Achillion, will present a corporate overview
at the 24th Annual Credit Suisse Healthcare Conference on
Wednesday, November 11, 2015 at 8:00 a.m. MT / 10:00 a.m. ET at The
Phoenician Hotel in Scottsdale, AZ.
The live audio and subsequent archived webcasts
of the Company's presentations will be accessible from the
Company's investor relations website, http://ir.achillion.com. The
audio recording will be archived for 30 days following the live
presentation. Please connect to Achillion's website several minutes
prior to the start of the presentation to ensure adequate time for
any software downloads that may be necessary.
About Achillion
Pharmaceuticals
Achillion is seeking to apply its expertise in
biology and structure-guided design and a deep understanding of
patient and clinician needs to develop innovative treatment
solutions aimed at improving patients’ lives. The company’s
scientific excellence, integrated capabilities and experienced team
position it to successfully achieve its goal of advancing new
products along the entire continuum from the bench to the patient.
Achillion’s pipeline is currently focused on small molecule
therapeutics for chronic hepatitis C viral infection (HCV) and
complement-related diseases through the inhibition of complement
factor D. More information is available at
http://www.achillion.com.
Company Contact:
Glenn Schulman
Achillion Pharmaceuticals, Inc.
Tel. (203) 752-5510
gschulman@achillion.com
Investors:
Mary Kay Fenton
Achillion Pharmaceuticals, Inc.
Tel. (203) 624-7000
mfenton@achillion.com
Achillion Pharmaceuticals (NASDAQ:ACHN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Achillion Pharmaceuticals (NASDAQ:ACHN)
Historical Stock Chart
From Sep 2023 to Sep 2024